HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dagnija Neimane Selected Research

Chromogenic Compounds

2/2005Increased tissue-type plasminogen activator: a facade in the fibrinolytic system in type 2 diabetes.
8/2002The ratio of plasminogen activator inhibitor type-1 activity to the concentration of plasminogen activator inhibitor type-1 protein in diabetes: adding insult to injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dagnija Neimane Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
02/2005 - 08/2002
1Myocardial Infarction
06/2004
1Chest Pain (Chest Pains)
06/2004
1Atherosclerosis
08/2002

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
02/2005 - 08/2002
2ImmunosorbentsIBA
02/2005 - 08/2002
2Plasminogen Activator Inhibitor 1IBA
02/2005 - 08/2002
2Tissue Plasminogen Activator (Alteplase)FDA Link
02/2005 - 06/2004
2Chromogenic CompoundsIBA
02/2005 - 08/2002
1Plasminogen InactivatorsIBA
02/2005
1AntigensIBA
02/2005
1TenecteplaseFDA Link
06/2004
1Proteins (Proteins, Gene)FDA Link
08/2002
1Troglitazone (Rezulin)FDA Link
08/2002

Therapy/Procedure

1Central Venous Catheters
08/2002